Jaap ten Oever

4.7k total citations
89 papers, 1.8k citations indexed

About

Jaap ten Oever is a scholar working on Epidemiology, Infectious Diseases and Applied Microbiology and Biotechnology. According to data from OpenAlex, Jaap ten Oever has authored 89 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Epidemiology, 26 papers in Infectious Diseases and 19 papers in Applied Microbiology and Biotechnology. Recurrent topics in Jaap ten Oever's work include Antibiotic Use and Resistance (19 papers), Patient Satisfaction in Healthcare (13 papers) and Infective Endocarditis Diagnosis and Management (12 papers). Jaap ten Oever is often cited by papers focused on Antibiotic Use and Resistance (19 papers), Patient Satisfaction in Healthcare (13 papers) and Infective Endocarditis Diagnosis and Management (12 papers). Jaap ten Oever collaborates with scholars based in Netherlands, United States and Germany. Jaap ten Oever's co-authors include Mihai G. Netea, Frank L. van de Veerdonk, Jeroen Slaats, Bart Jan Kullberg, Jeroen Schouten, Chantal P. Bleeker‐Rovers, Heiman Wertheim, Martin Jaeger, Marlies Hulscher and Diletta Rosati and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Jaap ten Oever

77 papers receiving 1.7k citations

Peers

Countries citing papers authored by Jaap ten Oever

Since Specialization

Citations

This map shows the geographic impact of Jaap ten Oever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaap ten Oever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaap ten Oever more than expected).

Fields of papers citing papers by Jaap ten Oever

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaap ten Oever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaap ten Oever. The network helps show where Jaap ten Oever may publish in the future.

Co-authorship network of co-authors of Jaap ten Oever

This figure shows the co-authorship network connecting the top 25 collaborators of Jaap ten Oever. A scholar is included among the top collaborators of Jaap ten Oever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaap ten Oever. Jaap ten Oever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Current practices and opportunities in antibiotic allergy delabelling: a national cross-sectional survey 2025 ·Clinical Microbiology and Infection ·(unknown), (unknown), (unknown), Mark de Boer, (unknown), Jaap ten Oever, (unknown), Marvin A. H. Berrevoets, Reinier M. van Hest, Jarne M. van Hattem, (unknown)	0
2	Diagnostic characteristics of the Rapid ESBL NP® test and ResistanceFinder 2SMART multiplex PCR for the detection of ESBL directly on urine samples 2025 ·European Journal of Clinical Microbiology & Infectious Diseases ·Martine Bot, Jacky Flipse, Suzanne Bongers, (unknown), (unknown), Antoinette A. T. P. Brink, Jacobien J. Hoogerwerf, Jaap ten Oever, Heiman Wertheim, Maurits P. A. van Meer	0
3	Risk conditions for invasive pneumococcal disease in adults: a systematic review and meta-analysis 2025 ·EClinicalMedicine ·(unknown), Federica Giardina, Jaap ten Oever, Amelieke J. H. Cremers	0
4	Duration of antibiotic therapy in the intensive care unit: factors influencing decision-making during multidisciplinary meetings 2025 ·BMJ Quality & Safety ·(unknown), Anke Oerlemans, (unknown), Johannes G. van der Hoeven, Evelien Oostdijk, Lennie Derde, Jaap ten Oever, Heiman Wertheim, Jeroen Schouten, Marlies Hulscher	1
5	Dutch guideline for the prevention and control of multidrug-resistant organisms in the hospital setting, 2024 update 2025 ·Antimicrobial Resistance and Infection Control ·(unknown), (unknown), Erik Bathoorn, (unknown), Jaap ten Oever, (unknown), (unknown), (unknown), Jan Vissers, Peter Molenaar, (unknown), Marjolein Kluytmans-van den Bergh, Andreas Voß, Haitske Graveland, Bart Versteeg, Juliëtte A. Severin	0
6	The effect of BCG vaccination in the elderly on infectious and non-infectious immune-mediated diseases 2024 ·Journal of Infection ·(unknown), (unknown), Esther Taks, Simone J.C.F.M. Moorlag, (unknown), Josephine van de Maat, Jaap ten Oever, Jacobien J. Hoogerwerf, Cornelis H. van Werkhoven, Marc J. M. Bonten, (unknown), Frits R. Rosendaal, Mihai G. Netea	3
7	The impact of implementing an endocarditis team in comparison to the classic heart team in a tertiary referral centre 2022 ·BMC Cardiovascular Disorders ·(unknown), (unknown), Guillaume S C Geuzebroek, Erik H.J.G. Aarntzen, (unknown), (unknown), Michel Verkroost, Laura Rodwell, Jaap ten Oever, Reinout van Crevel, Jesse Habets, Ilse J.E. Kouijzer, Robin Nijveldt	6
8	SARS-CoV-2 RNA in exhaled air of hospitalized COVID-19 patients 2022 ·Scientific Reports ·(unknown), (unknown), Kjerstin Lanke, Dimitri A. Diavatopoulos, Gijs J. Overheul, Mihai G. Netea, Jaap ten Oever, Reinout van Crevel, (unknown), Frank L. van de Veerdonk, Heiman Wertheim, Jeroen Schouten, Janette Rahamat–Langendoen, Ronald P. van Rij, Teun Bousema, Arjan van Laarhoven, Marien I. de Jonge	4
9	An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients 2022 ·Clinical Pharmacokinetics ·(unknown), Rob ter Heine, Jeroen Schouten, J. A. M. Raaijmakers, Jaap ten Oever, Eva Kolwijck, David M. Burger, Peter Pickkers, Tim Frenzel, Roger J. M. Brüggemann	11
10	Clinical characteristics and outcomes of 952 hospitalized COVID-19 patients in The Netherlands: A retrospective cohort study 2021 ·PLoS ONE ·(unknown), Josephine van de Maat, Karin Veerman, Jaap ten Oever, Nico Janssen, Evertine J. Abbink, Monique H. Reijers, Quirijn de Mast, Wouter Hoefsloot, Reinout van Crevel, Kitty Slieker, Marjan van Apeldoorn, Marc J. T. Blaauw, Anton S. M. Dofferhoff, Jacobien J. Hoogerwerf	27
11	A Multidisciplinary Approach to Fungal Infections: One-Year Experiences of a Center of Expertise in Mycology 2020 ·Journal of Fungi ·Nico Janssen, Roger J. M. Brüggemann, Monique H. Reijers, Stefanie Henriet, Jaap ten Oever, Quirijn de Mast, (unknown), Elizabeth de Kort, Bart Jan Kullberg, Mihai G. Netea, Jochem B. Buil, Janette Rahamat–Langendoen, (unknown), Eline W. Muilwijk, Jacques F. Meis, Paul E. Verweij, Frank L. van de Veerdonk	10
12	Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks? 2020 ·International Journal of Antimicrobial Agents ·(unknown), Chantal P. Bleeker‐Rovers, Rob ter Heine, Janette Rahamat–Langendoen, Quirijn de Mast, Jaap ten Oever, Teun Bousema, Reinout van Crevel, Heiman Wertheim	22
13	Nationwide survey of hospital antibiotic stewardship programs in France 2019 ·Médecine et Maladies Infectieuses ·Francesca Binda, Gianpiero Tebano, (unknown), Jaap ten Oever, Marlies Hulscher, Jeroen Schouten, Céline Pulcini	12
14	Incidence and microbiology of post-operative infections after radical cystectomy and ureteral stent removal; a retrospective cohort study 2019 ·BMC Infectious Diseases ·Eva Kolwijck, (unknown), (unknown), Antoine G. van der Heijden, J.P. Michiel Sedelaar, Jaap ten Oever	15
15	Praktijkgids - antimicrobial Stewardship in Nederland 2018 ·Data Archiving and Networked Services (DANS) ·Marvin A. H. Berrevoets, (unknown), (unknown), Martine G. Caris, (unknown), (unknown), Jaap ten Oever, I. T. M. A. Overdevest, Denise Telgt, Tom F.W. Wolfs	1
16	Quality of outpatient parenteral antimicrobial therapy (OPAT) care from the patient’s perspective: a qualitative study 2018 ·BMJ Open ·Marvin A. H. Berrevoets, Anke Oerlemans, Mirjam Tromp, Bart Jan Kullberg, Jaap ten Oever, Jeroen Schouten, Marlies Hulscher	28
17	Monitoring, documenting and reporting the quality of antibiotic use in the Netherlands: a pilot study to establish a national antimicrobial stewardship registry 2017 ·BMC Infectious Diseases ·Marvin A. H. Berrevoets, Jaap ten Oever, Tom Sprong, Reinier M. van Hest, (unknown), (unknown), Jeroen Schouten, Marlies Hulscher, Bart Jan Kullberg	19
18	Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions 2016 ·Journal of NeuroVirology ·(unknown), Jaap ten Oever, Peter J. Koopmans, Foekje F. Stelma, Saskia M. Burm, Jeffrey J. Bajramović, Marcel M. Verbeek, Marcel G. M. Olde Rikkert, Mihai G. Netea, Gerrit Koopman, André van der Ven	10
19	Characterization of the Acute Inflammatory Response in Measles Infection 2013 ·Journal of the Pediatric Infectious Diseases Society ·Jaap ten Oever, Anca Lelia Riza, (unknown), Cristina Cismaru, Mihai G. Netea, Adriana Slavcovici	9
20	Plasma PAI-1 levels are independently related to fatty liver and hypertriglyceridemia in familial combined hyperlipidemia, involvement of apolipoprotein E 2008 ·Thrombosis Research ·Martijn C.G.J. Brouwers, José W.P. Govers‐Riemslag, Casper G. Schalkwijk, Marleen M. J. van Greevenbroek, Carla Kallen, Otto Bekers, Marja P. van Dieijen‐Visser, Jaap ten Oever, (unknown), Tjerk W.A. de Bruin, Hugo Ten Cate, Coen D.A. Stehouwer	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact